NSF Feels Heat On Delayed Centers

WASHINGTON—The National Science Foundation’s science and technology centers program, intended to be a beacon for collaborative U.S. research that would speed applications to the marketplace, instead has become a lightning rod for criticism from the scientific community. NSF’s decision not to fund any such centers this fiscal year provoked keen disappointment among scientists, especially those who had raced to meet the January 15 deadline. A number of applicants echoed the

Written byStephen Greene
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON—The National Science Foundation’s science and technology centers program, intended to be a beacon for collaborative U.S. research that would speed applications to the marketplace, instead has become a lightning rod for criticism from the scientific community.

NSF’s decision not to fund any such centers this fiscal year provoked keen disappointment among scientists, especially those who had raced to meet the January 15 deadline. A number of applicants echoed the complaint of Robert Byer, research dean at Stanford Univer sity, that the process resulted in "a tremendous waste of scientific resources in this country.”

While many scientists criticized NSF’s procedure for soliciting applications, some also suggested ways for NSF to recoup part of the applicants’ collective investment. These range from an accelerated review and early ranking of the applications now awaiting fiscal 1989 funding, to making public (with the applicants’ permission) the major features of specific applications.

The foundation received ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies